JENAVALVE TECHNOLOGY
JenaValve Technology, Inc. is a medical device company focused on the design, development, and commercialization of innovative transcatheter heart valve solutions for the treatment of patients suffering from heart valve disease. The Company’s Trilogy™ Heart Valve System is a transcatheter aortic valve replacement (“TAVR”) system designed to treat patients with symptomatic, severe aortic regurgitation (“AR”) and aortic stenosis (“AS”) in high surgical risk patients. The Trilogy Sy... stem received CE Mark approval in May 2021, providing European physicians, for the first time, a device with true dual-disease treatment capabilities. JenaValve received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) to facilitate the review of ALIGN-AR, a pivotal trial in the U.S., as part of its premarket approval (“PMA”) application for the Trilogy Heart Valve System for the treatment of symptomatic, severe aortic regurgitation (AR) in high surgical risk patients. If approved, Trilogy would become the first and only TAVR system in the U.S. to be indicated for the treatment of AR patients. JenaValve is headquartered in Irvine, California, with additional locations in Leeds, U.K., and Munich, Germany. Additional information is available at www.jenavalve.com. US: CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use.
JENAVALVE TECHNOLOGY
Industry:
Health Care Manufacturing Medical Device
Founded:
2006-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.jenavalve.com
Total Employee:
101+
Status:
Active
Contact:
949-767-2110
Email Addresses:
[email protected]
Total Funding:
299.07 M USD
Technology used in webpage:
SPF Google Font API Domain Not Resolving Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API Unified Layer Google Maps For Work
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
InTouch Health
InTouch Health is the leader in Acute Care Telemedicine solutions.
Kerecis
Kerecis develops, manufactures, and markets implants and repair materials for the human body from omega3 rich fish skin.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Investors List
Valiance Asset Management
Valiance Asset Management investment in Series C - JenaValve Technology
Qatar Investment Authority
Qatar Investment Authority investment in Series C - JenaValve Technology
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series C - JenaValve Technology
Venture Incubator
Venture Incubator investment in Series C - JenaValve Technology
Andera Partners
Andera Partners investment in Series C - JenaValve Technology
Cormorant Asset Management
Cormorant Asset Management investment in Series C - JenaValve Technology
RMM
RMM investment in Series C - JenaValve Technology
Innovatus Capital Partners
Innovatus Capital Partners investment in Series C - JenaValve Technology
Peijia Medical
Peijia Medical investment in Series C - JenaValve Technology
Gimv
Gimv investment in Series C - JenaValve Technology
Key Employee Changes
| Date | New article |
|---|---|
| 2020-09-28 | JenaValve Technology Appoints Peter L. Spadaro Chief Commercial Officer |
Official Site Inspections
http://www.jenavalve.com Semrush global rank: 2.95 M Semrush visits lastest month: 5.52 K
- Host name: mail.smileselectdental.com
- IP address: 216.172.185.1
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
